Efficacy of Lansap combination therapy for eradication of H. pylori.
Nagahara
Akihito
A
Miwa
Hiroto
H
Hojo
Mariko
M
Yoshizawa
Takashi
T
Kawabe
Masato
M
Osada
Taro
T
Kurosawa
Akihiko
A
Ohkusa
Toshifumi
T
Watanabe
Sumio
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017291:Clarithromycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance
D000900:Anti-Bacterial Agents; D017291:Clarithromycin